Isan Chen
EVP, Chief Medical Officer at Mirati Therapeutics, Inc.
Filed with the SEC as CHEN ISAN
- Sold, on record
- $3.5M
- Dollars the filings state
- Form 4 sales
- 1
- Latest May 11, 2020
- Form 144 notices
- 0
- Proposed sales
- Quarters with a sale
- 0 of the last 8
- No sale in two years
- Companies
- 1
- Filed as an executive or holder
Companies
- Mirati Therapeutics, Inc.EVP, Chief Medical Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
1
Unusual
Form 4 sales per year, every sale on record.
Timeline
- May 11, 2020Unusual
Sold 45.8% of their holdings
$3.5M33,334 shares at $105.00
1 of 1
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| May 31, 2023 | Jun 2, 2023 | TYRA | Director | AwardedStock Option (Right to Buy) | 14,500 | 14,500 | SEC | ||
| Jun 13, 2022 | Jun 15, 2022 | TYRA | Director | AwardedStock Option (Right to Buy) | 14,500 | 14,500 | SEC | ||
| Sep 17, 2021 | Sep 17, 2021 | TYRA | Director | ConvertedSeries A Preferred Stock | 23,656 | 0 | SEC | ||
| Sep 17, 2021 | Sep 17, 2021 | TYRA | Director | Converted | 61,444 | 192,783 | SEC | ||
| May 11, 2020 | May 13, 2020 | Mirati Therapeutics, Inc. | EVP, Chief Medical Officer | Sold | 33,334 | $105.00 | $3.5M | 39,401 | SEC |
| May 11, 2020 | May 13, 2020 | Mirati Therapeutics, Inc. | EVP, Chief Medical Officer | Exercised or settledStock Options | 33,334 | 23,420 | SEC | ||
| May 11, 2020 | May 13, 2020 | Mirati Therapeutics, Inc. | EVP, Chief Medical Officer | Exercised options | 33,334 | $24.99 | $833k | 72,735 | SEC |
| Jan 29, 2020 | Jan 31, 2020 | Mirati Therapeutics, Inc. | EVP, Chief Medical Officer | Exercised or settledStock Options | 3,002 | 56,754 | SEC | ||
| Jan 29, 2020 | Jan 31, 2020 | Mirati Therapeutics, Inc. | EVP, Chief Medical Officer | Exercised options | 3,002 | $24.99 | $75k | 39,401 | SEC |
| Jan 23, 2019 | Jan 25, 2019 | Mirati Therapeutics, Inc. | EVP, Chief Medical Officer | Exercised or settledStock Options | 870 | 49,997 | SEC | ||
| Jan 23, 2019 | Jan 25, 2019 | Mirati Therapeutics, Inc. | EVP, Chief Medical Officer | Exercised options | 870 | $22.47 | $20k | 35,836 | SEC |
| Jan 17, 2019 | Jan 22, 2019 | Mirati Therapeutics, Inc. | EVP, Chief Medical Officer | AwardedOption Grant (Right to Buy) | 60,000 | 60,000 | SEC | ||
| Jul 16, 2018 | Jul 17, 2018 | Mirati Therapeutics, Inc. | EVP, Chief Medical Officer | Exercised or settledEmployee Stock Option (Right to Buy) | 1,867 | 25,908 | SEC | ||
| Jul 16, 2018 | Jul 17, 2018 | Mirati Therapeutics, Inc. | EVP, Chief Medical Officer | Exercised options | 1,867 | $20.91 | $39k | 34,582 | SEC |
| Apr 25, 2018 | Apr 26, 2018 | Mirati Therapeutics, Inc. | EVP, Chief Medical Officer | Exercised or settledEmployee Stock Option (Right to Buy) | 13,038 | 27,500 | SEC | ||
| Apr 25, 2018 | Apr 26, 2018 | Mirati Therapeutics, Inc. | EVP, Chief Medical Officer | Exercised options | 13,038 | $16.94 | $221k | 31,836 | SEC |
| Jan 18, 2018 | Jan 22, 2018 | Mirati Therapeutics, Inc. | EVP, Chief Medical Officer | AwardedOption Grant (Right to Buy) | 50,000 | 50,000 | SEC | ||
| Jan 26, 2017 | Jan 30, 2017 | Mirati Therapeutics, Inc. | Sr. VP, Chief Medical | AwardedOption Grant (Right to Buy) | 50,000 | 50,000 | SEC | ||
| Jan 22, 2016 | Jan 26, 2016 | Mirati Therapeutics, Inc. | Sr. Vice President, Chief Medi | AwardedStock Options | 60,000 | 60,000 | SEC | ||
| Jan 13, 2016 | Jan 15, 2016 | Mirati Therapeutics, Inc. | Sr.Vice President, Chief Medi | Exercised or settledIncentive Stock Option (right to buy) | 2,542 | 106,792 | SEC | ||
| Jan 13, 2016 | Jan 15, 2016 | Mirati Therapeutics, Inc. | Sr.Vice President, Chief Medi | Exercised options | 2,542 | $15.79 | $40k | 18,113 | SEC |
| Mar 9, 2015 | Mar 11, 2015 | Mirati Therapeutics, Inc. | Chief Medical & Dev't Officer | Exercised or settledEmployee Stock Option (Right to Buy) | 12,666 | 109,334 | SEC | ||
| Mar 9, 2015 | Mar 11, 2015 | Mirati Therapeutics, Inc. | Chief Medical & Dev't Officer | Exercised options | 12,666 | $15.79 | $200k | 12,666 | SEC |
| Feb 4, 2015 | Feb 5, 2015 | Mirati Therapeutics, Inc. | Chief Medical & Dev't Officer | AwardedEmployee Stock Option (Right to Buy) | 30,000 | 30,000 | SEC | ||
| May 21, 2014 | May 23, 2014 | Mirati Therapeutics, Inc. | Chief Medical & Dev't Officer | AwardedEmployee Stock Option (Right to Buy) | 6,600 | 6,600 | SEC | ||
| Nov 8, 2013 | Nov 12, 2013 | Mirati Therapeutics, Inc. | Chief Medical & Dev't Officer | AwardedEmployee Stock Option (Right to Buy) | 122,000 | 122,000 | SEC |
Sales and notices (1)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2020 | May 13, 2020 | Mirati Therapeutics, Inc. | EVP, Chief Medical Officer | Form 4 sale | 33,334 | $3.5M | 45.8% | Unusual | SEC |